510(k) Report

510(k) · Cleared

Cleared

cNeuro cMRI

K171328510(k) TraditionalCleared Jan 8, 2018248-day reviewClass II21 CFR 892.2050

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Combinostics OY · LLZ System, Image Processing, Radiological

Cleared on Jan 8, 2018 as substantially equivalent to K061855 (Cortechs Labs, Inc., 2006) and 1 other predicate after a 248-day review. Its family tree reaches back 2 generations to 2006. 1 later device descends from it.

Decided
Jan 8, 2018
Review
248 days
Class
Class II
Product code
LLZ
Recalls
None
Predicates
2

Its longest line of descent runs back 2 generations to K061855 (2006). 1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2023: 1 descendant clearedK061855 · Neuroquant · Cortechs Labs, Inc. · 2006K161148 · icobrain · Icometrix · 201620052010201520202025
Descendants, by generation 1 generation forward: 1 descendant K161148 · icobrain · Icometrix · 2016K061855 · Neuroquant · Cortechs Labs, Inc. · 20060
  1. Root · 2 generations backK061855 NeuroquantCortechs Labs, Inc. · 2006
  2. 1 generation backK161148 icobrainIcometrix · 2016
  3. This deviceK171328 cNeuro cMRICombinostics OY · 2018
  4. Descendant · cites it directly · 0 of its ownK231398 VUNO Med-DeepBrainVuno, Inc. · 2023

Most influential descendants

Showing 1 of 1 · See all
  • K231398VUNO Med-DeepBrainVuno, Inc. · 2023 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K061855NeuroquantCortechs Labs, Inc.2006—
−1K161148icobrainIcometrix2016—
0 (this device)K171328cNeuro cMRICombinostics OY2018—
+1K231398VUNO Med-DeepBrainVuno, Inc.2023—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202310
FIG. 1 — Lineage of K171328, 2006–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LLZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LLZ device

  1. #1 K230955 syngo Application Softwarescore 21.5 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K061855Neuroquant
Summary page 5
…Page 1 of 6 5.3 Predicate Device Primary predicate device Device NeuroQuant 510(k) # K061855 Manufacturer CorTechs Labs, Inc. 4690 Executive Drive, Suite 250 San Diego, CA 92…
Cortechs Labs, Inc.2006—
*K161148icobrain
Summary page 5
…rive, Suite 250 San Diego, CA 92121 USA Secondary predicate device Device icobrain 510(k) # K161148 Manufacturer Icometrix, Kolonel Begaultlaan 1b / 12 3012 Leuven, Belgium 5.4…
Icometrix2016—

Also cleared against K061855: 5 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K231398VUNO Med-DeepBrainVuno, Inc.20230

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 12 years and passes through 3 companies; a new generation was cleared every 10.0 years on median.
  • None of the 2 ancestors has a recall.
  • Of its descendants, K231398 (Vuno, Inc., 2023) has gone furthest, with 0 descendants of its own.
  • 5 other devices also cite its predicate K061855.

How does its category compare?

All LLZ devices

LLZ System, Image Processing, Radiological: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · LLZ

58in 2025

2007: 762008: 942009: 702010: 512011: 1062012: 822013: 952014: 782015: 642016: 822017: 782018: 1042019: 742020: 812021: 832022: 652023: 872024: 622025: 582026 (partial year): 45
2007high 106 (2011) · low 51 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LLZ

173in 2025

2007: 36 days median2008: 52 days median2009: 62 days median2010: 98 days median2011: 79 days median2012: 87 days median2013: 84 days median2014: 89 days median2015: 90 days median2016: 90 days median2017: 107 days median2018: 105 days median2019: 107 days median2020: 115 days median2021: 116 days median2022: 137 days median2023: 157 days median2024: 131 days median2025: 173 days median2026 (partial year): 110 days median
2007high 173 (2025) · low 36 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LLZ

11in 2025

2007: 202008: 322009: 212010: 172011: 302012: 122013: 642014: 62015: 162016: 122017: 52018: 72019: 22020: 62021: 32022: 42023: 82024: 62025: 112026 (partial year): 14
2007high 64 (2013) · low 2 (2019)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LLZ

116in 2025

2007: 1522008: 1542009: 1452010: 1452011: 4542012: 2662013: 1,1302014: 15,6312015: 2112016: 2902017: 1042018: 722019: 882020: 822021: 702022: 282023: 262024: 422025: 116
2007high 15,631 (2014) · low 26 (2023)2025

MAUDE reports naming product code LLZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007763620152
2008945232154
2009706221145
2010519817145
20111067930454
2012828712266
20139584641,130
20147889615,631
2015649016211
2016829012290
2017781075104
2018104105772
201974107288
202081115682
202183116370
202265137428
202387157826
202462131642
20255817311116
20264511014—

What is it indicated for?

cNeuro cMRI is intended for automatic labeling, quantification and visualization of segmentable brain structures from a set of MR images. The software is intended to automate the current manual process of identifying, labeling and quantifying the segmentable brain structures identified on MR images.

The intended user profile covers medical professionals who work with medical imaging. The intended operational environment is an office-like environment with a computer.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K171328: cNeuro cMRI.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K171328

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026